Tag: equity
-
Start-Up Offers Digital Health Prescriptions, Raises $1.8M
A new enterprise that offers electronic health service prescriptions is raising $1.8 million in seed funds and starting a program for prescribing digital health services simultaneously to groups of people.
-
Scientists, Investors Form $100M+ Tech Venture Fund
A group of entrepreneurs and leading scientists in the U.K. unveiled a venture investment fund that plans to back start-up companies developing a wide range of ground-breaking technologies.
-
Genomics-Blockchain Company Launches, Raises $4.3 Million
A new enterprise that promises to collect and protect a person’s genomic data with blockchain technology is starting up with the help of a genomics legend and $4.3 million in seed financing.
-
Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies
Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types.
-
Pfizer, Biotech Partner on RNA Flu Vaccine
A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins.
-
Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million
A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy.
-
Start-Up Developing Regenerative Liver Disease Treatments
A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions.
-
Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal
Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses.
-
Infographic – Harvard or Stanford? Venture Capitalists Revealed.
Our reporting on venture capital, much like other business media, tells about the companies investing in early-stage enterprises, but what about the people in the industry?
-
Univ. Spin-Off Developing Myelin Disease Treatments Unveiled
A spin-off enterprise from Case Western Reserve University is developing therapies designed to restore the myelin sheath around nerve cells destroyed in multiple sclerosis and other neurological disorders.